Survival of HIV-infected children: A cohort study from the Asia-Pacific region

Journal of Acquired Immune Deficiency Syndromes

Volumn 56, Issue 4, 2011, Pages 365-371

  Lumbiganon, Pagakrong ^a   Kariminia, Azar ^b   Aurpibul, Linda ^c   Hansudewechakul, Rawiwan ^d   Puthanakit, Thanyawee ^e   Kurniati, Nia ^f   Kumarasamy, Nagalingeswaran ^g   Chokephaibulkit, Kulkanya ^h   Nik Yusoff, Nik Khairulddin ⁱ   Vonthanak, Saphonn ^j   Moy, Fong Siew ^k   Razali, Kamarul Azahar Mohd ^l   Nallusamy, Revathy ^m   Sohn, Annette H ⁿ  

^a KHON KAEN UNIVERSITY   (Thailand)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c CHIANG MAI UNIVERSITY   (Thailand)

^d CHIANGRAI PRACHANUKROH HOSPITAL   (Thailand)

^e THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

^f CIPTO MANGUNKUSUMO HOSPITAL   (Indonesia)

^g YRG CENTRE FOR AIDS RESEARCH AND EDUCATION   (India)

^h MAHIDOL UNIVERSITY   (Thailand)

ⁱ HOSPITAL RAJA PEREMPUAN ZAINAB II   (Malaysia)

^j National Center for HIV/AIDS   (Cambodia)

^k Hospital Likas   (Malaysia)

^l HOSPITAL KUALA LUMPUR   (Malaysia)

^m HOSPITAL PULAU PINANG   (Malaysia)

ⁿ TREAT Asia/amfAR The Foundation for AIDS Research   (Thailand)

more..

Author keywords

antiretroviral therapy; Asia; HIV; mortality; pediatric survival

Indexed keywords

ANTIRETROVIRUS AGENT; EFAVIRENZ; NEVIRAPINE; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; STAVUDINE; ZIDOVUDINE;

ADOLESCENT; ARTICLE; ASIA; BODY WEIGHT; CD4 LYMPHOCYTE COUNT; CHILD; CHILD HEALTH CARE; COHORT ANALYSIS; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PACIFIC OCEAN; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SURVIVAL RATE; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ANTI-HIV AGENTS; ASIA; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; EARLY DIAGNOSIS; FEMALE; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; MALE; PACIFIC ISLANDS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 79952441846     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318207a55b     Document Type: Article

References (30)

1. Gibb DM, Duong T, Tookey PA, et al. Decline in mortality, AIDS, and hospital admissions in perinatally HIV-1 infected children in the United Kingdom and Ireland. BMJ. 2003;327:1019-1031.
2. Judd A, Doerholt K, Tookey PA, et al. Morbidity, mortality and response to treatment in children in the United Kingdom and Ireland with perinatally-acquired HIV infection during 1996-2006: planning for teenage and adult care. Clin Infect Dis. 2007;45:918-924. (Pubitemid 47580389)
3. Brady MT, Oleske JM, Williams PL, et al. Declines in mortality rates and changes in causes of death in HIV-1-infected children during the HAART era. J Acquir Immune Defic Syndr. 2010;53:86-89.
4. McConnell MS, Byers RH, Frederick T, et al. Trends in antiretroviral therapy use and survival rates in HIV-infected children and adolescents in the United States, 1989-2001. J Acquir Immune Defic Syndr. 2005;38: 488-494. (Pubitemid 40381559)
5. Chasombat S, Lertpiriyasuwat C, Thanprasertsuk S, et al. The national access to antiretroviral program for PHA (NAPHA) in Thailand. Southeast Asian J Trop Med Public Health. 2006;37:704-715. (Pubitemid 44606559)
6. Chearskul P, Chokephaibulkit K, Chearskul S, et al. Effect of antiretroviral therapy in human immunodeficiency virus-infected children. J Med Assoc Thai. 2000;88(Suppl):221-231.
7. Puthanakit T, Oberdorfer A, Akarathum N, et al. Efficacy of highly active antiretroviral therapy in HIV-infected children participating in Thailand's National Access to Antiretroviral Program. Clin Infect Dis. 2005;41: 100-107. (Pubitemid 40863751)
8. Puthanakit T, Aurpibul L, Oberdorfer P, et al. Hospitalization and mortality among HIV-infected children after receiving highly active antiretroviral therapy. Clin Infect Dis. 2007;44:599-604. (Pubitemid 46233267)
9. Puthanakit T, Aurpibul L, Oberdorfer P, et al. Sustained immunologic and virologic efficacy after four years of highly active antiretroviral therapy in human immunodeficiency virus infected children in Thailand. Pediatr Infect Dis J. 2007;26:953-956. (Pubitemid 47494171)
10. Little KE, Bland RM, Newell ML. Vertically acquired paediatric HIV infection: the challenges of providing comprehensive packages of care in resource-limited settings. Trop Med Int Health. 2008;13: 1098-1110.
11. Over M, Revenga A, Masaki E, et al. The economics of effective AIDS treatment in Thailand. AIDS. 2007;21(Suppl):105-116.
12. Kumarasamy N, Venkatesh KK, Devaleenol B, et al. Safety, tolerability and effectiveness of generic ART in HIV-infected children in South India. J Trop Pediatr. 2009;55:155-159.
13. Ciaranello AL, Chang Y, Margulis AV, et al. Effectiveness of pediatric antiretroviral therapy in resource-limited settings: a systematic review and meta-analysis. Clin Infect Dis. 2009;49:1915-1927.
14. PrasitsuebsaiW, Bowen AC, Pang J, et al. TREATAsia Pediatric Program. Pediatric HIV clinical care resources and management practices in Asia: a regional survey of the TREAT Asia pediatric network. AIDS Patients Care STDS. 2010;24:127-1231.
15. Kariminia A, Chokephaibulkit K, Pang J, et al. Cohort profile: The TREATAsia Pediatric HIVobservational database. Int J Epidemiol. 2010; 1-10 doi:10.1093/ije/dyp358.
16. World Health Organization. WHO Case Definitions of HIV for Surveillance and Revised Clinical Staging and Immunological Classifi- cation of HIV-Related Disease in Adults and Children. Geneva, Switzerland: World Health Organization, 2006.
17. WHO Multicentre Growth Reference Study Group. WHO Child Growth Standards: Length/Height-for-Age, Weight-for-Age, Weightfor- Length, Weight-for-Height and Body Mass Index for-Age: Methods and Development. Geneva, Switzerland: World Health Organization, 2006.
18. Kuczmarski RJ, Ogden CL, Guo SS, et al. 2000 CDC growth charts for the United States: methods and development. Vital Health Stat 11. 2002: 1-190.
19. The KIDS-ART-LINC Collaboration. Low risk of death, but substantial program attrition, in pediatric HIV treatment cohorts in Sub-Saharan Africa. J Acquir Immune Defic Syndr. 2008;49:523-531.
20. de Martino M, Tovo PA, Balducci M, et al. Reduction in mortality with availability of antiretroviral therapy for children with perinatal HIV-1 infection. Italian Register for HIV Infection in Children and the Italian National AIDS Registry. JAMA. 2000;284:190-197. (Pubitemid 30460862)
21. Sanchez JM, Ramos Amador JT, Fernandez de Miguel S, et al. Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children. Pediatr Infect Dis J. 2003;22:863-867. (Pubitemid 37288607)
22. Viani RM, Araneta MR, Deville JG, et al. Decrease in hospitalization and mortality rates among children with perinatally acquired HIV type 1 infection receiving highly active antiretroviral therapy. Clin Infect Dis. 2004;39:725-731. (Pubitemid 39180447)
23. Fassinou P, Elenga N, Rouet F, et al. Highly active antiretroviral therapies among HIV-1-infected children in Abidjan, Cote d'Ivoire. AIDS. 2004;18: 1905-1913. (Pubitemid 39313206)
24. George E, Noel F, Bois G, et al. Antiretroviral therapy for HIV-1-infected children in Haiti. J Infect Dis. 2007;195:1411-1418. (Pubitemid 46717458)
25. Sirisanthana V. Demographic and clinical characteristic of symptomatic vertical HIV-infected children at Chiang Mai University Hospital. J Infect Dis Antimicrob Agents. 1996;13:89-93.
26. Lumbiganon P, Kosalaraksa P, Loapaiboon M. Survival of children with AIDS: experience in a university hospital in northeast Thailand. J Med Assoc Thai. 2000;83:652-656.
27. Katona P, Katona-Apte J. The interaction between nutrition and infection. Clin Infect Dis. 2008;46:1582-1588. (Pubitemid 351706741)
28. Ivers LC, Cullen KA, Freedberg KA, et al. HIV/AIDS, undernutrition, and food insecurity. Clin Infect Dis. 2009;49:1096-1102.
29. Wamalwa DC, Obimbo EM, Farquhar C, et al. Predictors of mortality in HIV-1 infected children on antiretroviral therapy in Kenya: a prospective cohort. BMC Pediatr. 2010;10:33. E-pub ahead of print.
30. Sauvageot D, Schaefer M, Olson D, et al. Antiretroviral therapy outcomes in resource-limited settings for HIV-infected children <,5 years of age. Pediatrics. 2010;125:e1039-e1047. E-pub